Physician profile

Shruti A Patel

Foot & Ankle Surgery · Vienna, VA

NPI 1992187082

$47,246.18

in general payments reported to CMS, 2019-2025

43 companies · $384 in 2025

The $384 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).

See the full distribution for Foot & Ankle Surgery

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Education$7,500.00
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$5,000.00
Travel and Lodging$2,913.05
Food and Beverage$2,704.88
Consulting Fee$2,500.00

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Arthrex, INC. $22,038.86 2019-2024 Distal Extremities Implants Foot & Ankle Dynanite Staples
Supreme Orthopedic Systems, LLC $6,233.35 2020-2025
Medline Industries LP $5,000.00 2024 Medline, Medline Unite, Pending
Stryker Corporation $2,981.23 2019-2025 Axs Infinity Ls, Ortholoc 2 Lapifuse
Ossio INC $2,704.23 2023-2024
Linvatec Corporation $2,500.00 2024 Biobrace 23mm
Wright Medical Technology, INC. $2,154.11 2019-2020
Medical Device Business Services, INC. $907.08 2019
Melinta Therapeutics, LLC $312.13 2020-2023 Kimyrsa
Horizon Therapeutics Plc $235.16 2020-2022
Abbott Laboratories $185.15 2024 Diamondback Peripheral
Fortis Surgical, LLC $171.83 2025
Integra Lifesciences Corporation $143.04 2019-2021
Embody, INC. $137.01 2022
Ortho Dermatologics, A Division of Bausch Health US, LLC $136.27 2020-2021
Show all 43 companies
CompanyGeneral paymentsYearsTop products
Zimmer Biomet Holdings, INC. $133.36 2019
Liberty Surgical INC. $132.13 2019
Depuy Synthes Sales INC. $131.29 2019-2022
Bone Support INC. $128.90 2024 Cerament G, Ceramentbone Void Filler
Crossroads Extremity Systems, LLC $93.34 2019
Fusion Orthopedics USA, LLC $87.27 2025
Tenex Health INC. $83.89 2019
Paratek Pharmaceuticals, INC. $67.81 2021-2022
Biocomposites INC $62.12 2024
Treace Medical Concepts, INC. $54.67 2023
Sebela Pharmaceuticals INC. $41.30 2022
Nabriva Therapeutics, Plc $40.80 2021-2022
Nevro Corp. $31.61 2024 Senza
Abbvie INC. $30.66 2023
Trice Medical, INC. $25.96 2022
Smith+Nephew, INC. $25.87 2021
Acera Surgical, INC. $24.70 2024 Restrata Wound Matrix
Medtronic, INC. $23.67 2023 Intellis Adaptivestim
Terumo Medical Corporation $23.11 2022
Arteriocyte Medical Systems, INC. $22.28 2023 Magellan
Orthofix Medical, INC. $21.96 2021
Alfasigma USA, INC. $20.50 2022
Heron Therapeutics, INC. $19.26 2022
Sandoz INC. $18.57 2020
Osteomed LLC $16.98 2021
Avanos Medical $16.15 2021
Glaxosmithkline, LLC. $15.49 2019
Misonix INC $13.08 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Shruti A Patel

$47,246.18

in general payments reported 2019-2025

Years
2019-2025
Top company
Arthrex, INC.
Context
The $384 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).

https://glasscript.com/doctor/1401832/shruti-a-patel

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.